As part of the annual meetings of the Coordinated Action on Host-Virus Interactions: Basic and Translational HIV Research (CA41), the ThéGéVec Group is hosting its first symposium on November 28th 2025: "Shaping the Future of Gene Therapy with New Vectors".
28 November 2025
The ThéGéVec working group, affiliated with Coordinated Action on Host-Virus Interactions: Basic and Translational HIV Research (CA41), is excited to announce its first symposium: “Shaping the Future of Gene Therapy with New Vectors”, marking a key milestone for this newly established working group focused on advancing research in vectorology and gene therapy.
This event will be held in person on 28th November, 2025 at Institut Pasteur.
The symposium will bring together leading experts and researchers to discuss the latest innovations in viral and non-viral vectors technologies and their therapeutic applications. Special emphasis will be placed on fostering collaboration within the scientific community and exploring new strategies for accelerating progress in the field. Research from all areas of vectorology and gene therapy is welcomed for presentation.
Registration is now open and closes on November 21st. The symposium is free to attend, but registration is mandatory (in-person event only).
Abstract submission is now open until September 15th.
Registration Abstract submission
BE READY PLUS carried-out an awareness campaign between September and November 2025 to introduce the forthcoming EU Pandemic Preparedness Partnership to citizens.
10 November 2025